These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 28859784)

  • 21. New-onset left bundle branch block-associated idiopathic nonischemic cardiomyopathy and time from diagnosis to cardiac resynchronization therapy: The NEOLITH II study.
    Wang NC; Li JZ; Adelstein EC; Althouse AD; Sharbaugh MS; Jain SK; Mendenhall GS; Shalaby AA; Voigt AH; Saba S
    Pacing Clin Electrophysiol; 2018 Feb; 41(2):143-154. PubMed ID: 29314085
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The effect of intermittent atrial tachyarrhythmia on heart failure or death in cardiac resynchronization therapy with defibrillator versus implantable cardioverter-defibrillator patients: a MADIT-CRT substudy (Multicenter Automatic Defibrillator Implantation Trial With Cardiac Resynchronization Therapy).
    Ruwald AC; Pietrasik G; Goldenberg I; Kutyifa V; Daubert JP; Ruwald MH; Jons C; McNitt S; Wang P; Zareba W; Moss AJ
    J Am Coll Cardiol; 2014 Apr; 63(12):1190-1197. PubMed ID: 24333490
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A randomized study of cardiac resynchronization therapy defibrillator versus dual-chamber implantable cardioverter-defibrillator in ischemic cardiomyopathy with narrow QRS: the NARROW-CRT study.
    Muto C; Solimene F; Gallo P; Nastasi M; La Rosa C; Calvanese R; Iengo R; Canciello M; Sangiuolo R; Diemberger I; Ciardiello C; Tuccillo B
    Circ Arrhythm Electrophysiol; 2013 Jun; 6(3):538-45. PubMed ID: 23592833
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Atrioventricular delay programming and the benefit of cardiac resynchronization therapy in MADIT-CRT.
    Brenyo A; Kutyifa V; Moss AJ; Mathias A; Barsheshet A; Pouleur AC; Knappe D; McNitt S; Polonsky B; Huang DT; Solomon SD; Zareba W; Goldenberg I
    Heart Rhythm; 2013 Aug; 10(8):1136-43. PubMed ID: 23712031
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Survival after cardiac resynchronization therapy: results from 50 084 implantations.
    Leyva F; Zegard A; Okafor O; de Bono J; McNulty D; Ahmed A; Marshall H; Ray D; Qiu T
    Europace; 2019 May; 21(5):754-762. PubMed ID: 30590500
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Comparative Effectiveness of Cardiac Resynchronization Therapy Among Patients With Heart Failure and Atrial Fibrillation: Findings From the National Cardiovascular Data Registry's Implantable Cardioverter-Defibrillator Registry.
    Khazanie P; Greiner MA; Al-Khatib SM; Piccini JP; Turakhia MP; Varosy PD; Masoudi FA; Curtis LH; Hernandez AF;
    Circ Heart Fail; 2016 Jun; 9(6):. PubMed ID: 27296396
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [ECG score to predict ICD therapies in patients with nonischemic cardiomyopathy and primary prophylactic CRT-D].
    Grett M; Christ M; Röing Gen Nölke JP; Trappe HJ
    Herzschrittmacherther Elektrophysiol; 2017 Mar; 28(1):48-53. PubMed ID: 28204917
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cardioverter-defibrillator reduces mortality risk in eligible ischemic and non-ischemic cardiomyopathy patients: Sub-analysis of the multi-center Improve SCA study.
    Singh B; Hsieh YC; Liu YB; Lin KH; Joung B; Rodriguez DA; Chasnoits AR; Huang D; Zhang S; O'Brien JE; Lexcen DR; Cerkvenik J; Van Dorn B; Ching CK
    Indian Heart J; 2023; 75(2):115-121. PubMed ID: 36736459
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Applicability of a risk score for prediction of the long-term benefit of the implantable cardioverter defibrillator in patients receiving cardiac resynchronization therapy.
    Barra S; Looi KL; Gajendragadkar PR; Khan FZ; Virdee M; Agarwal S
    Europace; 2016 Aug; 18(8):1187-93. PubMed ID: 26566940
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Implantable cardioverter-defibrillator therapy among patients with non-ischaemic vs. ischaemic cardiomyopathy for primary prevention of sudden cardiac death.
    Amara N; Boveda S; Defaye P; Klug D; Treguer F; Amet D; Perier MC; Gras D; Algalarrondo V; Bouzeman A; Piot O; Deharo JC; Fauchier L; Babuty D; Bordachar P; Sadoul N; Marijon E; Leclercq C;
    Europace; 2018 Jan; 20(1):65-72. PubMed ID: 28082419
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cardiac resynchronization therapy guided by late gadolinium-enhancement cardiovascular magnetic resonance.
    Leyva F; Foley PW; Chalil S; Ratib K; Smith RE; Prinzen F; Auricchio A
    J Cardiovasc Magn Reson; 2011 Jun; 13(1):29. PubMed ID: 21668964
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Utility of Cardiac Magnetic Resonance in Assessing Arrhythmic Risk in Patients With Nonischemic Cardiomyopathy Undergoing Biventricular Pacing.
    El-Damaty A; Sayed M; El-Maghawry M; Kandil H; Hassan M
    Pacing Clin Electrophysiol; 2024 Nov; 47(11):1528-1538. PubMed ID: 39311305
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Fragmented QRS Is a Novel Risk Factor for Ventricular Arrhythmic Events After Receiving Cardiac Resynchronization Therapy in Nonischemic Cardiomyopathy.
    Igarashi M; Tada H; Yamasaki H; Kuroki K; Ishizu T; Seo Y; Machino T; Murakoshi N; Sekiguchi Y; Noguchi Y; Nogami A; Aonuma K
    J Cardiovasc Electrophysiol; 2017 Mar; 28(3):327-335. PubMed ID: 27925329
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Scar Characterization to Predict Life-Threatening Arrhythmic Events and Sudden Cardiac Death in Patients With Cardiac Resynchronization Therapy: The GAUDI-CRT Study.
    Acosta J; Fernández-Armenta J; Borràs R; Anguera I; Bisbal F; Martí-Almor J; Tolosana JM; Penela D; Andreu D; Soto-Iglesias D; Evertz R; Matiello M; Alonso C; Villuendas R; de Caralt TM; Perea RJ; Ortiz JT; Bosch X; Serra L; Planes X; Greiser A; Ekinci O; Lasalvia L; Mont L; Berruezo A
    JACC Cardiovasc Imaging; 2018 Apr; 11(4):561-572. PubMed ID: 28780194
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A metric for evaluating the cardiac response to resynchronization therapy.
    Ge Y; Ruwald AC; Kutyifa V; McNitt S; Polonsky S; Klein H; Goldenberg I; Solomon SD; Foster E; Zareba W; Moss AJ
    Am J Cardiol; 2014 Apr; 113(8):1371-7. PubMed ID: 24607029
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The clinical outcome of cardiac resynchronization therapy in post-surgical valvular cardiomyopathy.
    Leyva F; Umar F; Taylor RJ; Steeds RP; Frenneaux MP
    Europace; 2016 May; 18(5):732-8. PubMed ID: 26802014
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cardiac Resynchronization Therapy Reduces Ventricular Arrhythmias in Primary but Not Secondary Prophylactic Implantable Cardioverter Defibrillator Patients: Insight From the Resynchronization in Ambulatory Heart Failure Trial.
    Sapp JL; Parkash R; Wells GA; Yetisir E; Gardner MJ; Healey JS; Thibault B; Sterns LD; Birnie D; Nery PB; Sivakumaran S; Essebag V; Dorian P; Tang AS
    Circ Arrhythm Electrophysiol; 2017 Mar; 10(3):. PubMed ID: 28292754
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Long-term outcomes of cardiac resynchronization therapy in adult congenital heart disease.
    Leyva F; Zegard A; Qiu T; de Bono J; Thorne S; Clift P; Marshall H; Hudsmith L
    Pacing Clin Electrophysiol; 2019 Jun; 42(6):573-580. PubMed ID: 30908673
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The benefits of defibrillator in heart failure patients with cardiac resynchronization therapy: A meta-analysis.
    Long YX; Hu Y; Cui DY; Hu S; Liu ZZ
    Pacing Clin Electrophysiol; 2021 Feb; 44(2):225-234. PubMed ID: 33372697
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Implantable cardioverter defibrillators for primary prevention in patients with nonischemic cardiomyopathy: A systematic review and meta-analysis.
    Akel T; Lafferty J
    Cardiovasc Ther; 2017 Jun; 35(3):. PubMed ID: 28129469
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.